Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Haanen J, Obeid M, Spain L, Carbonnel F, Wang Y, Robert C, Lyon AR, Wick W, Kostine M, Peters S, Jordan K, Larkin J; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Haanen J, et al. Among authors: lyon ar. Ann Oncol. 2022 Dec;33(12):1217-1238. doi: 10.1016/j.annonc.2022.10.001. Epub 2022 Oct 18. Ann Oncol. 2022. PMID: 36270461 Free article. No abstract available.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Curigliano G, et al. Among authors: lyon ar. Ann Oncol. 2020 Feb;31(2):171-190. doi: 10.1016/j.annonc.2019.10.023. Ann Oncol. 2020. PMID: 31959335 Free PMC article.
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction.
Andres MS, Ramalingam S, Rosen SD, Baksi J, Khattar R, Kirichenko Y, Young K, Yousaf N, Okines A, Huddart R, Harrington K, Furness AJS, Turajlic S, Pickering L, Popat S, Larkin J, Lyon AR. Andres MS, et al. Among authors: lyon ar. Cardiooncology. 2022 Nov 24;8(1):21. doi: 10.1186/s40959-022-00147-w. Cardiooncology. 2022. PMID: 36424659 Free PMC article.
Treatment specific toxicities: Hormones, antihormones, radiation therapy.
Plummer C, Steingart RM, Jurczak W, Iakobishvili Z, Lyon AR, Plastaras JP, Minotti G. Plummer C, et al. Among authors: lyon ar. Semin Oncol. 2019 Dec;46(6):414-420. doi: 10.1053/j.seminoncol.2019.01.006. Epub 2019 Nov 19. Semin Oncol. 2019. PMID: 31784040 Review.
Letter by Cardinale et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial".
Cardinale D, Lyon AR, López-Fernández T. Cardinale D, et al. Among authors: lyon ar. Circulation. 2024 May 28;149(22):e1219-e1220. doi: 10.1161/CIRCULATIONAHA.123.068069. Epub 2024 May 28. Circulation. 2024. PMID: 38805580 Free article. No abstract available.
Perfect is the enemy of good: Reply to Struikmans et al.
Aznar MC, Bergler-Klein J, Boriani G, Cutter DJ, Hurkmans C, Levis M, López-Fernández T, Lyon AR, Maraldo MV. Aznar MC, et al. Among authors: lyon ar. Radiother Oncol. 2024 Oct 17:110585. doi: 10.1016/j.radonc.2024.110585. Online ahead of print. Radiother Oncol. 2024. PMID: 39423960 No abstract available.
403 results